Body | Page 197 of 274 | SpiritIndia.com

Exercise :: No time to exercise

Those who maintain that the busy pace of life offers no time to exercise have just run out of another excuse, unless of course they can’t spare three minutes to exercise. The “catch” is that the exercise consists of short bursts of intense effort separated by a few minutes of recovery, meaning a single training session lasts about 20 min. However, a new study published in the Journal of Physiology shows that performing three of those sessions each week provides the same benefits as that achieved by up to two hours of daily moderate exercise.

Breast Cancer :: Exercise helps breast cancer patients avoid anemia

Women undergoing radiation treatment for breast cancer benefit from moderate intensity, regular aerobic activity, according to a new study. A peer-reviewed journal of the American Cancer Society, the study found that exercise improved the oxygen capacity of patients and maintained levels of red blood cells during radiation treatment. In contrast, women who did not exercise experienced significant declines in their oxygen capacity. This is the first study to investigate the effect of exercise during treatment.

Health :: The common cold – no cure in sight

What’s the best treatment for a cold? Some say rest and lots of liquids, others say to feed a cold and starve a fever. But what if a person has a cold with a fever? Does medication help?

Psychiatry :: First Mani Bhaumik Award to UW Scientist for Insights into Brain’s Neuroplasticity

The Cousins Center for Psychoneuroimmunology at UCLA has named University of Wisconsin’s Richard Davidson as the first recipient of The Mani Bhaumik Award. The award was established earlier this year to support scientists in the international community who advance the understanding of the brain and the conscious mind in healing through visionary research, books and education. Bhaumik, co-inventor of the laser technology that made LASIK surgery possible, has funded the annual $10,000 award.

Herpes :: Merck’s shingles vaccine Zostavax, Zoster Vaccine Live for herpes zoster

Merck & Co., Inc. announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend that adults 60 years of age and older be vaccinated with ZOSTAVAX? [Zoster Vaccine Live (Oka/Merck)] to help prevent shingles (herpes zoster), a frequently painful disease marked by a blistering rash.

Tooth Decay :: New Weapon in Fight Against Tooth Decay

A group of scientists representing the UCLA School of Dentistry; the UCLA Department of Microbiology, Immunology and Molecular Genetics, and C3 Jian Corporation have succeeded in creating a pheromone-guided “smart” anti-microbial peptide capable of selectively eliminating Streptococcus mutans, a leading bacterial cause of tooth decay, in 30 seconds.

Crohn’s Disease :: Promising results in tough-to-treat crohn’s disease patients

Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.

Smoking :: Exercise helps smokers to quit without side effects

Exercise, jogging and fitness is not only an effective way to control body weight, but it might also help smokers quit their bad habit. According to a new study conducted by researchers at the American College of Physicians, smokers who combine traditional anti-smoking techniques with physical exercise are more likely of never using the drug ever again than those who resort only to nicotine replacements.

Dental Health :: Promising Approach to Prevent Tooth Decay

Preventing cavities could one day involve the dental equivalent of a military surgical strike. A team of researchers supported by the National Institute of Dental and Craniofacial Research report they have created a new smart anti-microbial treatment that can be chemically programmed in the laboratory to seek out and kill a specific cavity-causing species of bacteria, leaving the good bacteria untouched.

Pain :: Gene variation affects pain sensitivity and risk of chronic pain

A new NIH-funded study shows that a specific gene variant in humans affects both sensitivity to short-term (acute) pain in healthy volunteers and the risk of developing chronic pain after one kind of back surgery. Blocking increased activity of this gene after nerve injury or inflammation in animals prevented development of chronic pain.